‘Better decisions and shorter project timelines’: Optibrium taps InfoChem to up offering

By Melissa Fassbender

- Last updated on GMT

(Image: Getty/metamorworks)
(Image: Getty/metamorworks)

Related tags Drug discovery Design Software Research Preclinical contract research Informatics

Optibrium develops software for drug discovery and today announces a collaboration with InfoChem GmbH, a cheminformatics company, to provide users with a computer-aided synthesis design tool.

According to the companies, the collaboration will provide users of StarDrop – Optibrium’s lead product – with access to ICSYNTH light, an entry-level version of InfoChem’s computer-aided synthesis design (CASD) software, which enables the generation of synthesis pathways for a target molecule.

Dr. Matthew Segall, Optibrium’s CEO told us the InfoChem’s deisgn tool will be a “valuable contribution to StarDrop’s comprehensive range of optional plug-in modules.”

Segall added, “StarDrop ensures that scientists can quickly understand structure-activity relationships, identify potential liabilities and design new compounds with the highest chance of success, leading to better decisions and shorter project timelines.”

Optibrium company works closely with a range of customers and collaborators, including global pharma, biotech, and academic groups, among others. Segall in a press release that the partnership with InfoChem “continues our collaborative approach to working with leading providers of technology and services for drug discovery and other chemistry fields."

“We have developed StarDrop to seamlessly connect with a wide range of informatics systems thus giving our customers ultimate choice and flexibility, and providing everything they need for effective compound design and optimization through a single interface,”​ he added.

Related news

Show more

Related products

show more

Saama accelerates data review processes

Saama accelerates data review processes

Content provided by Saama | 25-Mar-2024 | Infographic

In this new infographic, learn how Saama accelerates data review processes. Only Saama has AI/ML models trained for life sciences on over 300 million data...

More Data, More Insights, More Progress

More Data, More Insights, More Progress

Content provided by Saama | 04-Mar-2024 | Case Study

The sponsor’s clinical development team needed a flexible solution to quickly visualize patient and site data in a single location

Related suppliers

Follow us


View more